Home > Cardiology > ACC 2022 > Interventional and Structural Cardiology > 1-year CLASP TR results support tricuspid regurgitation repair

1-year CLASP TR results support tricuspid regurgitation repair

Presented By
Prof. Adam Greenbaum, Emory University School of Medicine, USA
Conference
ACC 2022
Trial
CLASP TR
Transcatheter valve repair with the PASCAL system provided further validation for transcatheter edge-to-edge repair. The prospective, multicentre CLASP TR study reported significant reductions in tricuspid regurgitation (TR) and improved quality of life (QoL) at 1 year.   Prof. Adam Greenbaum (Emory University School of Medicine, GA, USA) presented the first interim results of the CLASP TR study [1]. CLASP TR is a prospective, single-arm, multicentre study (NCT03745313) designed to evaluate the safety and performance of the PASCAL transcatheter valve repair system in patients with symptomatic severe TR [2]. The primary endpoint was the composite of...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on